Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Association between clinicopathologic characteristics and BRAFV600E expression in Chinese patients with Langerhans cell histiocytosis.

Huang H, Lu T, Sun Y, Li S, Li J, Xu K, Feng RE, Xu ZJ.

Thorac Cancer. 2019 Oct;10(10):1984-1992. doi: 10.1111/1759-7714.13179. Epub 2019 Aug 23.

2.

BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay.

Tatsuno M, Shioda Y, Iwafuchi H, Yamazaki S, Iijima K, Takahashi C, Ono H, Uchida K, Okamura O, Matubayashi M, Okuyama T, Matsumoto K, Yoshioka T, Nakazawa A.

Diagn Pathol. 2016 Apr 19;11:39. doi: 10.1186/s13000-016-0489-z.

3.

Frequent BRAFV600E mutation has no effect on tumor invasiveness in patients with Langerhans cell histiocytosis.

Wei R, Wang Z, Li X, Shu Y, Fu B.

Biomed Rep. 2013 May;1(3):365-368. Epub 2013 Jan 25.

4.

Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis.

Héritier S, Hélias-Rodzewicz Z, Lapillonne H, Terrones N, Garrigou S, Normand C, Barkaoui MA, Miron J, Plat G, Aladjidi N, Pagnier A, Deville A, Gillibert-Yvert M, Moshous D, Lefèvre-Utile A, Lutun A, Paillard C, Thomas C, Jeziorski E, Nizard P, Taly V, Emile JF, Donadieu J.

Br J Haematol. 2017 Aug;178(3):457-467. doi: 10.1111/bjh.14695. Epub 2017 Apr 25.

PMID:
28444728
5.

[BRAF-V600E mutation and its clinical significance in children with Langerhans cell histiocytosis].

Tang X, Guo X, Sun LY, Ai Y, Yang X, Sun JJ, Wu JR, Gao J.

Zhongguo Dang Dai Er Ke Za Zhi. 2018 Apr;20(4):290-294. Chinese.

6.

[BRAF V600E Mutation in Chinese Patients with Langerhans Cell Histiocytosis and Its Clinical Significance].

Cheng XY, Li Y, Zhou J, Shu YG, Li XL, Fu B.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Apr;23(2):526-32. doi: 10.7534/j.issn.1009-2137.2015.02.045. Chinese.

PMID:
25948218
7.

Genetic homogeneity of adult Langerhans cell histiocytosis lesions: Insights from BRAFV600E mutations in adult populations.

Selway JL, Harikumar PE, Chu A, Langlands K.

Oncol Lett. 2017 Oct;14(4):4449-4454. doi: 10.3892/ol.2017.6774. Epub 2017 Aug 18.

8.

BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases.

Roden AC, Hu X, Kip S, Parrilla Castellar ER, Rumilla KM, Vrana JA, Vassallo R, Ryu JH, Yi ES.

Am J Surg Pathol. 2014 Apr;38(4):548-51. doi: 10.1097/PAS.0000000000000129.

PMID:
24625419
9.

BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.

Héritier S, Emile JF, Barkaoui MA, Thomas C, Fraitag S, Boudjemaa S, Renaud F, Moreau A, Peuchmaur M, Chassagne-Clément C, Dijoud F, Rigau V, Moshous D, Lambilliotte A, Mazingue F, Kebaili K, Miron J, Jeziorski E, Plat G, Aladjidi N, Ferster A, Pacquement H, Galambrun C, Brugières L, Leverger G, Mansuy L, Paillard C, Deville A, Armari-Alla C, Lutun A, Gillibert-Yvert M, Stephan JL, Cohen-Aubart F, Haroche J, Pellier I, Millot F, Lescoeur B, Gandemer V, Bodemer C, Lacave R, Hélias-Rodzewicz Z, Taly V, Geissmann F, Donadieu J.

J Clin Oncol. 2016 Sep 1;34(25):3023-30. doi: 10.1200/JCO.2015.65.9508. Epub 2016 Jul 5.

10.

High Prevalence of BRAF V600E Mutations in Langerhans Cell Histiocytosis of Head and Neck in Chinese Patients.

Liu X, Zhang Y, Zhou CX.

Int J Surg Pathol. 2019 Jun 17:1066896919855774. doi: 10.1177/1066896919855774. [Epub ahead of print]

PMID:
31203679
11.

BRAF V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis.

Ozer E, Sevinc A, Ince D, Yuzuguldu R, Olgun N.

Pediatr Dev Pathol. 2019 Oct;22(5):449-455. doi: 10.1177/1093526619847859. Epub 2019 May 9.

PMID:
31072207
12.

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.

Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, Idoyaga J, Ruzo A, Lupo PJ, Hicks MJ, Shih A, Simko SJ, Abhyankar H, Chakraborty R, Leboeuf M, Beltrão M, Lira SA, Heym KM, Bigley V, Collin M, Manz MG, McClain K, Merad M, Allen CE.

J Exp Med. 2014 Apr 7;211(4):669-83. doi: 10.1084/jem.20130977. Epub 2014 Mar 17. Erratum in: J Exp Med. 2015 Feb 9;212(2):281.

13.

The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis.

Ballester LY, Cantu MD, Lim KPH, Sarabia SF, Ferguson LS, Renee Webb C, Allen CE, McClain KL, Mohila CA, Punia JN, Roy A, López-Terrada DH, John Hicks M, Fisher KE.

Hematol Oncol. 2018 Feb;36(1):307-315. doi: 10.1002/hon.2388. Epub 2017 Feb 20.

PMID:
28219109
14.

MAPK/ERK signal pathway alterations in patients with Langerhans Cell Histiocytosis.

Novosad O, Skrypets T, Pastushenko Y, Titorenko I, Martynchyk A, Skachkova O, Inomistova M, Gorbach A, Khranovska N, Kryachok I.

Klin Onkol. Spring 2018;31(2):130-136. doi: 10.14735/amko2018130.

PMID:
29708356
15.

Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis.

Mourah S, How-Kit A, Meignin V, Gossot D, Lorillon G, Bugnet E, Mauger F, Lebbe C, Chevret S, Tost J, Tazi A.

Eur Respir J. 2016 Jun;47(6):1785-96. doi: 10.1183/13993003.01677-2015. Epub 2016 Apr 13.

16.

Identification of the V600D mutation in Exon 15 of the BRAF oncogene in congenital, benign langerhans cell histiocytosis.

Kansal R, Quintanilla-Martinez L, Datta V, Lopategui J, Garshfield G, Nathwani BN.

Genes Chromosomes Cancer. 2013 Jan;52(1):99-106. doi: 10.1002/gcc.22010. Epub 2012 Sep 21.

PMID:
22996177
17.

BRAF V600E mutation correlates with suppressive tumor immune microenvironment and reduced disease-free survival in Langerhans cell histiocytosis.

Zeng K, Wang Z, Ohshima K, Liu Y, Zhang W, Wang L, Fan L, Li M, Li X, Wang Y, Yu Z, Yan Q, Guo S, Wei J, Guo Y.

Oncoimmunology. 2016 Jun 14;5(7):e1185582. doi: 10.1080/2162402X.2016.1185582. eCollection 2016 Jul.

18.

Activating BRAF V600E mutation in aggressive pediatric Langerhans cell histiocytosis: demonstration by allele-specific PCR/direct sequencing and immunohistochemistry.

Méhes G, Irsai G, Bedekovics J, Beke L, Fazakas F, Rózsa T, Kiss C.

Am J Surg Pathol. 2014 Dec;38(12):1644-8. doi: 10.1097/PAS.0000000000000304.

PMID:
25118810
19.

Inflammatory serum cytokines and chemokines increase associated with the disease extent in pediatric Langerhans cell histiocytosis.

Morimoto A, Oh Y, Nakamura S, Shioda Y, Hayase T, Imamura T, Kudo K, Imashuku S; Japan Langerhans cell histiocytosis Study Group.

Cytokine. 2017 Sep;97:73-79. doi: 10.1016/j.cyto.2017.05.026. Epub 2017 Jun 2.

PMID:
28582647
20.

BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases.

Alayed K, Medeiros LJ, Patel KP, Zuo Z, Li S, Verma S, Galbincea J, Cason RC, Luthra R, Yin CC.

Hum Pathol. 2016 Jun;52:61-7. doi: 10.1016/j.humpath.2015.12.029. Epub 2016 Feb 1.

PMID:
26980021

Supplemental Content

Support Center